-
Signature
-
YuFan Stephanie Wang, Attorney-in-Fact
-
Issuer symbol
-
PRGS
-
Transactions as of
-
01 Nov 2024
-
Net transactions value
-
-$134,443
-
Form type
-
4
-
Filing time
-
05 Nov 2024, 16:18:37 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PRGS |
Common Stock |
Sale |
$12,804 |
-200 |
-3.7% |
$64.02 |
5,199 |
01 Nov 2024 |
Direct |
F1, F2 |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$151,521 |
+3,556 |
+68% |
$42.61 |
8,755 |
01 Nov 2024 |
Direct |
|
| transaction |
PRGS |
Common Stock |
Sale |
$227,655 |
-3,556 |
-41% |
$64.02 |
5,199 |
01 Nov 2024 |
Direct |
F1 |
| transaction |
PRGS |
Common Stock |
Options Exercise |
$103,662 |
+2,330 |
+45% |
$44.49 |
7,529 |
01 Nov 2024 |
Direct |
|
| transaction |
PRGS |
Common Stock |
Sale |
$149,167 |
-2,330 |
-31% |
$64.02 |
5,199 |
01 Nov 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PRGS |
Employee Stock Options (Right to buy) |
Options Exercise |
$0 |
-3,556 |
-47% |
$0.000000 |
4,053 |
01 Nov 2024 |
Common Stock |
3,556 |
$42.61 |
Direct |
F3 |
| transaction |
PRGS |
Employee Stock Options (Right to buy) |
Options Exercise |
$0 |
-2,330 |
-25% |
$0.000000 |
6,990 |
01 Nov 2024 |
Common Stock |
2,330 |
$44.49 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: